• Home
    • About Us
    • More About the George Consortium
    • 2012 Workshop Report
    • Focus Areas
    • COVID-19 Law and Policy Briefings
    • About Act for Public Health
    • Public Health Litigation Tracking
    • Partner Events
    • Spring 2024 | Act for Public Health Convening
    • Convening Attendees
    • Report: Protecting Public Health in the Courts
    • Public Health Authority Litigation Updates
    • COVID-19 Policy Playbook
    • COVID-19 Policy Playbook II
    • Law & Policy Briefings
    • Public Comments
    • Amicus Briefs
    • Subscribe | Submit a Case
Menu

Public Health Law Watch

Street Address
Boston , MA
Phone Number
An initiative of the George Consortium

Your Custom Text Here

Public Health Law Watch

  • Home
  • George Consortium
    • About Us
    • More About the George Consortium
    • 2012 Workshop Report
    • Focus Areas
    • COVID-19 Law and Policy Briefings
  • Act for Public Health
    • About Act for Public Health
    • Public Health Litigation Tracking
    • Partner Events
  • Events
    • Spring 2024 | Act for Public Health Convening
    • Convening Attendees
  • Resources & Publications
    • Report: Protecting Public Health in the Courts
    • Public Health Authority Litigation Updates
    • COVID-19 Policy Playbook
    • COVID-19 Policy Playbook II
    • Law & Policy Briefings
    • Public Comments
    • Amicus Briefs
  • Contact Us
    • Subscribe | Submit a Case

"Benefits, Limitations, and Value of Abuse-Deterrent Opioids" in JAMA Internal Medicine

December 13, 2017 Guest User

Two members of our team - Dr. Gregory Curfman and Professor Leo Beletsky - and friend of PHLW Ameet Sarpatwari have an important new piece out in JAMA Internal Medicine entitled "Benefits, Limitations, and Value of Abuse Deterrent Opioids." 

Read more
Tags opioids, abuse deterrent, substance use disorders